FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

38372311000001102: Nubeqa 300mg tablets (Bayer Plc) 112 tablet 7 x 16 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 10-Jun 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1383671000001110 Nubeqa 300mg tablets (Bayer Plc) 112 tablet 7 x 16 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1383681000001112 Nubeqa 300mg tablets (Bayer Plc) 112 tablet 7 x 16 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Nubeqa 300mg tablets (Bayer Plc) 112 tablet 7 x 16 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Nubeqa 300mg tablets (Bayer Plc) 112 tablet 7 x 16 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Nubeqa 300mg tablets (Bayer Plc) 112 tablet 7 x 16 tablets Is a Darolutamide 300mg tablets 112 tablet true Inferred relationship Existential restriction modifier
Nubeqa 300mg tablets (Bayer Plc) 112 tablet 7 x 16 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Nubeqa 300mg tablets (Bayer Plc) 112 tablet 7 x 16 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Nubeqa 300mg tablets (Bayer Plc) 112 tablet 7 x 16 tablets Has AMP Nubeqa 300mg tablets (Bayer Plc) true Inferred relationship Existential restriction modifier
Nubeqa 300mg tablets (Bayer Plc) 112 tablet 7 x 16 tablets Has excipient Lactose false Inferred relationship Existential restriction modifier
Nubeqa 300mg tablets (Bayer Plc) 112 tablet 7 x 16 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Nubeqa 300mg tablets (Bayer Plc) 112 tablet 7 x 16 tablets Has specific active ingredient Darolutamide false Inferred relationship Existential restriction modifier
Nubeqa 300mg tablets (Bayer Plc) 112 tablet 7 x 16 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Nubeqa 300mg tablets (Bayer Plc) 112 tablet 7 x 16 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Nubeqa 300mg tablets (Bayer Plc) 112 tablet 7 x 16 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Nubeqa 300mg tablets (Bayer Plc) 112 tablet 7 x 16 tablets Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Nubeqa 300mg tablets (Bayer Plc) 112 tablet 7 x 16 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Nubeqa 300mg tablets (Bayer Plc) 112 tablet 7 x 16 tablets Has specific active ingredient Darolutamide true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start